An unusual case report of gingival overgrowth associated with the use of leflunomide
Authors
Ferdi Yavuz; Umit Guzelkucuk;
Leflunomide is an immunomodulatory agent with antiproliferative activity that is used for the treatment of rheumatoid arthritis. Leflunomide induced side effects are hepatotoxicity, immunosuppression, skin reactions, peripheral neuropathy, hypertension, diarrhea, interstitial lung disease, and rarely oral mucosal lesions. Here, we presented an unusual case of gingival overgrowth associated with the use of leflunomide, which improved after ceasing the drug.
Ferdi Yavuz
The Clinic of Physical Medicine and Rehabilitation, Military Hospital of Etimesgut, Ankara-Turkey
Umit Guzelkucuk
Department of Physical Medicine and Rehabilitation, Gulhane Military Medical Academy, TAF Rehabilitation Center, Ankara-Turkey
The Clinic of Physical Medicine and Rehabilitation, Military Hospital of Etimesgut, Ankara-Turkey
Umit Guzelkucuk
Department of Physical Medicine and Rehabilitation, Gulhane Military Medical Academy, TAF Rehabilitation Center, Ankara-Turkey